![Keith Fandrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Fandrick
Chief Operating Officer at
IRULYA THERAPEUTICS INC.
Net worth: - $ as of 30/09/2026
Profile
Dr. Keith R.
Fandrick is a Chief Operating Officer at IRulya Therapeutics, Inc. Dr. Fandrick was previously employed as a Chief Operating Officer by OrphAI Therapeutics, Inc. He received his undergraduate degree from the University of California, a graduate degree from Harvard University, an MBA from Kenan-Flagler Business School and a doctorate degree from Harvard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/10/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Keith Fandrick active positions
| Companies | Position | Start |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Chief Operating Officer | 08/10/2026 |
Former positions of Keith Fandrick
| Companies | Position | End |
|---|---|---|
AI Therapeutics, Inc.
 AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Chief Operating Officer | - |
Education of Keith Fandrick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenan-Flagler Business School
 Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Health Technology |
- Stock Market
- Insiders
- Keith Fandrick
